HSBA

1,068

-2.63%↓

HSBA

1,068

-2.63%↓

HSBA

1,068

-2.63%↓

HSBA

1,068

-2.63%↓

HSBA

1,068

-2.63%↓

Search

ConvaTec Group PLC

Avatud

SektorRahandus

230.8 -4.86

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

228.4

Max

243

Põhinäitajad

By Trading Economics

Sissetulek

-7.1M

105M

Müük

4.1M

1.2B

P/E

Sektori keskmine

29.5

31.165

Aktsiakasum

0.08

Dividenditootlus

2.77

Kasumimarginaal

8.882

Töötajad

10,000

EBITDA

-7.9M

281M

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+26.66% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

2.77%

3.89%

Turustatistika

By TradingEconomics

Turukapital

-122M

4.9B

Eelmine avamishind

235.66

Eelmine sulgemishind

230.8

Uudiste sentiment

By Acuity

50%

50%

223 / 528 Pingereas Finance

ConvaTec Group PLC Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

26. veebr 2025, 13:37 UTC

Market Talk

European Stocks on Track for Record Close as Earnings Lift Mood -- Market Talk

Võrdlus sarnastega

Hinnamuutus

ConvaTec Group PLC Prognoos

Hinnasiht

By TipRanks

26.66% tõus

12 kuu keskmine prognoos

Keskmine 311.33 GBX  26.66%

Kõrge 375 GBX

Madal 250 GBX

Põhineb 10 Wall Streeti analüütiku instrumendi ConvaTec Group PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

10 ratings

9

Osta

1

Hoia

0

Müü

Sentiment

By Acuity

223 / 528 Pingereas Rahandus

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Üle keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest ConvaTec Group PLC

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer. In addition, the company offers continence care products and services for people with urinary continence issues related to spinal cord injuries, multiple sclerosis, spina bifida, and other causes, as well as critical care devices and products used in intensive care units and hospital settings. Further, it provides infusion care solutions comprising disposable infusion sets for diabetes insulin pumps, or for pumps used in continuous subcutaneous infusion treatments for conditions such as parkinson's disease. The company sells its products to pharmacies, hospitals, and other acute and post-acute healthcare service providers directly or through distributors and wholesalers. It serves a range of customers, including healthcare providers, patients, and manufacturers. ConvaTec Group PLC was founded in 1978 and is headquartered in London, the United Kingdom.
help-icon Live chat